Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.8 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.8 |
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |